Wayne D. Tilley

21.2k total citations · 1 hit paper
213 papers, 12.9k citations indexed

About

Wayne D. Tilley is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Wayne D. Tilley has authored 213 papers receiving a total of 12.9k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Pulmonary and Respiratory Medicine, 86 papers in Molecular Biology and 82 papers in Genetics. Recurrent topics in Wayne D. Tilley's work include Prostate Cancer Treatment and Research (99 papers), Estrogen and related hormone effects (72 papers) and Hormonal and reproductive studies (41 papers). Wayne D. Tilley is often cited by papers focused on Prostate Cancer Treatment and Research (99 papers), Estrogen and related hormone effects (72 papers) and Hormonal and reproductive studies (41 papers). Wayne D. Tilley collaborates with scholars based in Australia, United States and United Kingdom. Wayne D. Tilley's co-authors include Theresa E. Hickey, Grant Buchanan, Lisa M. Butler, Michael J. McPhaul, Jacqueline M. Bentel, Marco Marcelli, Stephen N. Birrell, Carmela Ricciardelli, Norman M. Greenberg and Villis R. Marshall and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Wayne D. Tilley

206 papers receiving 12.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prostate cancer in a transgenic mouse.

1995 1.0k citations Wayne D. Tilley et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wayne D. Tilley Australia	69	6.5k	5.2k	3.9k	3.3k	3.2k	213	12.9k
Donald J. Tindall United States	70	8.4k 1.3×	7.0k 1.4×	3.0k 0.8×	2.4k 0.7×	2.7k 0.8×	206	16.1k
Zoran Čulig Austria	61	5.5k 0.8×	5.7k 1.1×	2.3k 0.6×	3.2k 1.0×	2.9k 0.9×	221	11.7k
Helmut Klocker Austria	67	6.9k 1.1×	6.6k 1.3×	2.2k 0.6×	3.0k 0.9×	3.1k 1.0×	364	15.1k
Jan Trapman Netherlands	70	8.8k 1.4×	7.9k 1.5×	5.3k 1.3×	1.9k 0.6×	2.4k 0.8×	201	15.7k
Donna M. Peehl United States	61	5.6k 0.9×	3.5k 0.7×	1.7k 0.4×	2.3k 0.7×	2.2k 0.7×	211	11.8k
Paul S. Rennie Canada	55	4.9k 0.8×	3.8k 0.7×	2.3k 0.6×	1.7k 0.5×	1.6k 0.5×	216	9.4k
Robert J. Matusik United States	51	5.7k 0.9×	3.7k 0.7×	2.2k 0.5×	1.8k 0.5×	1.6k 0.5×	147	9.7k
Norman M. Greenberg United States	53	5.3k 0.8×	3.4k 0.6×	1.7k 0.4×	3.1k 0.9×	1.8k 0.6×	123	10.2k
Robert L. Sutherland Australia	78	10.4k 1.6×	3.3k 0.6×	5.0k 1.3×	7.8k 2.3×	3.8k 1.2×	236	19.2k
Suzanne A.W. Fuqua United States	69	9.3k 1.4×	1.8k 0.4×	6.6k 1.7×	6.4k 1.9×	4.0k 1.2×	203	16.6k

Countries citing papers authored by Wayne D. Tilley

Since Specialization

Citations

This map shows the geographic impact of Wayne D. Tilley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wayne D. Tilley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wayne D. Tilley more than expected).

Fields of papers citing papers by Wayne D. Tilley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wayne D. Tilley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wayne D. Tilley. The network helps show where Wayne D. Tilley may publish in the future.

Co-authorship network of co-authors of Wayne D. Tilley

This figure shows the co-authorship network connecting the top 25 collaborators of Wayne D. Tilley. A scholar is included among the top collaborators of Wayne D. Tilley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wayne D. Tilley. Wayne D. Tilley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ieso, Michael L. De, et al.. (2024). Are androgen receptor agonists a treatment option in bladder cancer?. The Journal of Steroid Biochemistry and Molecular Biology. 245. 106623–106623.

Palmieri, Carlo, Hannah M. Linden, Stephen N. Birrell, et al.. (2024). Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial. The Lancet Oncology. 25(3). 317–325. 20 indexed citations

Shrestha, Raj K., Zeyad D. Nassar, Adrienne R. Hanson, et al.. (2024). ACSM1 and ACSM3 Regulate Fatty Acid Metabolism to Support Prostate Cancer Growth and Constrain Ferroptosis. Cancer Research. 84(14). 2313–2332. 18 indexed citations

Laven‐Law, Geraldine, Van T.M. Nguyen, Simak Ali, et al.. (2023). Selective inhibition of CDK9 in triple negative breast cancer. Oncogene. 43(3). 202–215. 10 indexed citations

Kowalczyk, Wioleta, Denis B. Scanlon, Wayne D. Tilley, et al.. (2023). Designing Fluorescent Nuclear Permeable Peptidomimetics to Target Proliferating Cell Nuclear Antigen. Journal of Medicinal Chemistry. 66(15). 10354–10363. 1 indexed citations

Huang, Xuan, Konstantin I. Momot, Tony Blick, et al.. (2023). Portable NMR for the investigation of models of mammographic density ex vivo: Androgens antagonise the promotional effect of oestrogen. 10(3-4). 77–97.

Laajala, Teemu D., et al.. (2021). Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes. Cancers. 13(13). 3272–3272. 15 indexed citations

Scanlon, Denis B., et al.. (2021). A cell permeable bimane-constrained PCNA-interacting peptide. RSC Chemical Biology. 2(5). 1499–1508. 4 indexed citations

Ricciardelli, Carmela, Tina Bianco‐Miotto, Shalini Jindal, et al.. (2018). The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease Outcome. Clinical Cancer Research. 24(10). 2328–2341. 62 indexed citations

10.

Lu, Miao, Lin Yang, Rui Li, et al.. (2017). Disrupting Androgen Receptor Signaling Induces Snail-Mediated Epithelial–Mesenchymal Plasticity in Prostate Cancer. Cancer Research. 77(11). 3101–3112. 66 indexed citations

11.

Ponnusamy, Suriyan, Christopher C. Coss, Thirumagal Thiyagarajan, et al.. (2017). Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer. Cancer Research. 77(22). 6282–6298. 70 indexed citations

12.

Singhal, Hari, Marianne E. Greene, Gerard A. Tarulli, et al.. (2016). Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer. Science Advances. 2(6). e1501924–e1501924. 105 indexed citations

13.

Castro, Mauro A. A., Inês de Santiago, Thomas M. Campbell, et al.. (2015). Regulators of genetic risk of breast cancer identified by integrative network analysis. Nature Genetics. 48(1). 12–21. 138 indexed citations

14.

Comstock, Clay E.S., Michael A. Augello, Jonathan F. Goodwin, et al.. (2013). Targeting cell cycle and hormone receptor pathways in cancer. Oncogene. 32(48). 5481–5491. 81 indexed citations

15.

Dean, Jeffry L., A. Kathleen McClendon, Theresa E. Hickey, et al.. (2012). Therapeutic response to CDK4/6 inhibition in breast cancer defined by ex vivo analyses of human tumors. Cell Cycle. 11(14). 2756–2761. 182 indexed citations

16.

Centenera, Margaret M., Joanna L. Gillis, Adrienne R. Hanson, et al.. (2012). Evidence for Efficacy of New Hsp90 Inhibitors Revealed by Ex Vivo Culture of Human Prostate Tumors. Clinical Cancer Research. 18(13). 3562–3570. 87 indexed citations

17.

Peters, Amelia A., Grant Buchanan, Carmela Ricciardelli, et al.. (2009). Androgen Receptor Inhibits Estrogen Receptor-α Activity and Is Prognostic in Breast Cancer. Cancer Research. 69(15). 6131–6140. 309 indexed citations

18.

Ricciardelli, Carmela, Michael Jackson, Catherine S. Choong, et al.. (2008). Elevated levels of HER‐2/neu and androgen receptor in clinically localized prostate cancer identifies metastatic potential. The Prostate. 68(8). 830–838. 36 indexed citations

19.

Buchanan, Grant, Carmela Ricciardelli, Jonathan M. Harris, et al.. (2007). Control of Androgen Receptor Signaling in Prostate Cancer by the Cochaperone Small Glutamine–Rich Tetratricopeptide Repeat Containing Protein α. Cancer Research. 67(20). 10087–10096. 70 indexed citations

20.

Tilley, Wayne D., Marco Marcelli, & Michael J McPhaul. (1990). Recent studies of the androgen receptor: new insights into old questions. Molecular and Cellular Endocrinology. 68(2-3). C7–C10. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact